Lorem ipsum dolor sit amet

Lorem ipsum dolor sit amet, consetetur sadipscing elitr, sed diam nonumy eirmod tempor invidunt ut labore et dolore magna aliquyam erat, sed diam voluptua. At vero eos et accusam et justo duo dolores et ea rebum. Stet clita kasd gubergren, no sea takimata sanctus est Lorem ipsum dolor sit amet. Lorem ipsum dolor sit amet, consetetur sadipscing elitr, sed diam nonumy eirmod tempor invidunt ut labore.

Download now

CASE STUDY

How leading Ohio-based specialty pharmacy engaged 60% of patients remotely and streamlined refill assessments with MHALink™

With increasing challenges in gaining access to new therapies from limited drug distribution networks, implementing value-based care initiatives continues to be a top priority for specialty pharmacies. Manufacturers are looking for specialty pharmacies to demonstrate an innovative and collaborative approach to patient care that results in high patient satisfaction and outcomes. These challenges, coupled with the increased patient demand for real-time electronic communication, and a cumbersome refill assessment process, led Ohio-based Elixir Specialty Pharmacy to look for a technology solution that could help ensure a high-touch, patient-centric approach to their operations.

“Our organization is deeply committed to delivering the highest levels of patient care. With the CitusHealth platform we are reaching even greater heights of patient service and further establishing the value-based care that our patients and partners have come to expect from Elixir Specialty Pharmacy. We are very impressed with the results we have already achieved and we look forward to extending the platform across all aspects of our business.”

Misty Willard, PharmD, R.PH., Director Specialty Operations
Elixir Specialty Pharmacy

Empowering Staff and Patients with Real-Time Communication

Learn how Elixir Specialty Pharmacy was able to quickly implement MHALink powered by CitusHealth's HIPAA-compliant, secure, messaging tools, electronic forms, and eSignatures to engage 60% of its patients remotely while also reducing refill processing time by more than 50%, and increasing adherence rates within the first few months of using the solution.